Literature DB >> 11135049

Poor agreement in recognition of abnormal mitoses: requirement for standardized and robust definitions.

M Barry1, S K Sinha, M B Leader, E W Kay.   

Abstract

AIMS: The finding of abnormal mitoses is a helpful feature in differentiating between benign and malignant neoplasia and has prognostic significance for some tumours. As the use of a histopathological variable is limited by the reproducibility of its recognition, we tested the interobserver agreement in the classification of abnormal mitoses among histopathologists. METHODS adn
RESULTS: Ten practising histopathologists were shown 30 potential mitotic figures and were asked to classify these as 'normal mitoses', 'abnormal mitoses' or 'not mitoses' according to the criteria each pathologist used in their routine practice. The results were analysed using kappa statistics. Overall agreement was only fair with a combined kappa of 0.31 and there was unanimous categorization of only four of 30 test items, none of which was called abnormal. The poorest result was obtained for the category 'abnormal mitosis' with only slight agreement (kappa 0.19). Agreement for the other categories varied from moderate (kappa = 0.45) for 'not a mitosis' to fair (kappa = 0.26) for 'normal mitosis'. Comparison of the results for observer pairs showed that for 12 out of the 45 possible pairings, there was no more agreement than might be expected by chance alone.
CONCLUSION: Agreement is poor among practising histopathologists in the recognition of abnormal mitoses. A standardized and robust definition is needed if diagnostic and prognostic significance is accorded to the finding of an abnormal mitosis in the context of neoplasia.

Entities:  

Mesh:

Year:  2001        PMID: 11135049     DOI: 10.1046/j.1365-2559.2001.01034.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  What is better/reliable, mitosis counting or Ki67/MIB1 staining?

Authors:  Mark Kriegsmann; Arne Warth
Journal:  Transl Lung Cancer Res       Date:  2016-10

2.  A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.

Authors:  Kyuichi Kadota; Kei Suzuki; Christos Colovos; Camelia S Sima; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Mod Pathol       Date:  2011-10-07       Impact factor: 7.842

3.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Authors:  Kyuichi Kadota; Kei Suzuki; Stefan S Kachala; Emily C Zabor; Camelia S Sima; Andre L Moreira; Akihiko Yoshizawa; Gregory J Riely; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Mod Pathol       Date:  2012-04-13       Impact factor: 7.842

Review 4.  Diagnostic and prognostic biomarkers in melanoma.

Authors:  David Weinstein; Jennifer Leininger; Carl Hamby; Bijan Safai
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

5.  Diagnostic cellular abnormalities in neoplastic and non-neoplastic lesions of the epidermis: a morphological and statistical study.

Authors:  Saurabh Malhotra; Viktoryia Kazlouskaya; Christian Andres; Jiang Gui; Dirk Elston
Journal:  J Cutan Pathol       Date:  2013-02-11       Impact factor: 1.587

6.  Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.

Authors:  Arne Warth; Ludger Fink; Annette Fisseler-Eckhoff; Danny Jonigk; Marius Keller; German Ott; Ralf J Rieker; Peter Sinn; Stephan Söder; Alex Soltermann; Klaus Willenbrock; Wilko Weichert
Journal:  Virchows Arch       Date:  2013-04-05       Impact factor: 4.064

7.  Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic Lesions.

Authors:  Michelle Wetzk; Nannette Grübling; Almuth Forberger; Jörg Klengel; Jan Kuhlmann; Pauline Wimberger; Maren Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-01-10       Impact factor: 2.915

Review 8.  Role of Biomarkers in the Integrated Management of Melanoma.

Authors:  Piyu Parth Naik
Journal:  Dis Markers       Date:  2021-12-30       Impact factor: 3.434

9.  CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.

Authors:  Radhika Aiyappa-Maudsley; Sarah J Storr; Emad A Rakha; Andrew R Green; Ian O Ellis; Stewart G Martin
Journal:  J Pathol Clin Res       Date:  2022-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.